Benign prostatic hyperplasia

Part 1- diagnosis

Research output: Contribution to journalArticle

11 Citations (Scopus)
3 Downloads (Pure)

Abstract

Lower urinary tract symptoms are bothersome yet often under-reported by older men. Symptom severity generally progresses over time but is rarely life threatening. Many clinical and lifestyle factors can cause or worsen the symptoms but can be modified by simple interventions. Asking about how bothersome the symptoms are and how they affect the patient’s quality of life is useful for considering whether to suggest additional treatment. Benign prostatic hyperplasia does not increase risk of prostate cancer but is associated with higher levels of prostate specific antigen. These levels are associated with prostate volume and may be useful when combined with symptom and health status measures for assessing potential effectiveness of treatment options
Most men can be assessed and treated by primary care clinicians on the basis of the severity of their symptoms and how bothersome they are. Additional diagnostic evaluations include diaries, uroflowmetry, bladder pressure studies, urinary tract imaging, and urethrocystoscopy.
Original languageEnglish
Pages (from-to)146-149
Number of pages3
JournalBritish Medical Journal
Volume336
Issue number7636
DOIs
Publication statusPublished - 19 Jan 2008

Fingerprint

Prostatic Hyperplasia
Lower Urinary Tract Symptoms
Prostate-Specific Antigen
Urinary Tract
Health Status
Life Style
Prostate
Prostatic Neoplasms
Primary Health Care
Urinary Bladder
Quality of Life
Pressure
Therapeutics

Cite this

Benign prostatic hyperplasia : Part 1- diagnosis. / Wilt, Timothy; N'Dow, James Michael Olu.

In: British Medical Journal, Vol. 336, No. 7636, 19.01.2008, p. 146-149.

Research output: Contribution to journalArticle

@article{caf267a36d39463a9165f707906a9e35,
title = "Benign prostatic hyperplasia: Part 1- diagnosis",
abstract = "Lower urinary tract symptoms are bothersome yet often under-reported by older men. Symptom severity generally progresses over time but is rarely life threatening. Many clinical and lifestyle factors can cause or worsen the symptoms but can be modified by simple interventions. Asking about how bothersome the symptoms are and how they affect the patient’s quality of life is useful for considering whether to suggest additional treatment. Benign prostatic hyperplasia does not increase risk of prostate cancer but is associated with higher levels of prostate specific antigen. These levels are associated with prostate volume and may be useful when combined with symptom and health status measures for assessing potential effectiveness of treatment options Most men can be assessed and treated by primary care clinicians on the basis of the severity of their symptoms and how bothersome they are. Additional diagnostic evaluations include diaries, uroflowmetry, bladder pressure studies, urinary tract imaging, and urethrocystoscopy.",
author = "Timothy Wilt and N'Dow, {James Michael Olu}",
year = "2008",
month = "1",
day = "19",
doi = "10.1136/bmj.39421.685023.AE",
language = "English",
volume = "336",
pages = "146--149",
journal = "BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7636",

}

TY - JOUR

T1 - Benign prostatic hyperplasia

T2 - Part 1- diagnosis

AU - Wilt, Timothy

AU - N'Dow, James Michael Olu

PY - 2008/1/19

Y1 - 2008/1/19

N2 - Lower urinary tract symptoms are bothersome yet often under-reported by older men. Symptom severity generally progresses over time but is rarely life threatening. Many clinical and lifestyle factors can cause or worsen the symptoms but can be modified by simple interventions. Asking about how bothersome the symptoms are and how they affect the patient’s quality of life is useful for considering whether to suggest additional treatment. Benign prostatic hyperplasia does not increase risk of prostate cancer but is associated with higher levels of prostate specific antigen. These levels are associated with prostate volume and may be useful when combined with symptom and health status measures for assessing potential effectiveness of treatment options Most men can be assessed and treated by primary care clinicians on the basis of the severity of their symptoms and how bothersome they are. Additional diagnostic evaluations include diaries, uroflowmetry, bladder pressure studies, urinary tract imaging, and urethrocystoscopy.

AB - Lower urinary tract symptoms are bothersome yet often under-reported by older men. Symptom severity generally progresses over time but is rarely life threatening. Many clinical and lifestyle factors can cause or worsen the symptoms but can be modified by simple interventions. Asking about how bothersome the symptoms are and how they affect the patient’s quality of life is useful for considering whether to suggest additional treatment. Benign prostatic hyperplasia does not increase risk of prostate cancer but is associated with higher levels of prostate specific antigen. These levels are associated with prostate volume and may be useful when combined with symptom and health status measures for assessing potential effectiveness of treatment options Most men can be assessed and treated by primary care clinicians on the basis of the severity of their symptoms and how bothersome they are. Additional diagnostic evaluations include diaries, uroflowmetry, bladder pressure studies, urinary tract imaging, and urethrocystoscopy.

U2 - 10.1136/bmj.39421.685023.AE

DO - 10.1136/bmj.39421.685023.AE

M3 - Article

VL - 336

SP - 146

EP - 149

JO - BMJ

JF - BMJ

SN - 0959-8146

IS - 7636

ER -